Just want to make absolutely sure this is seen by the right people.

Singingsoul asked about WHY the AstraZeneca vaccine was having a clotting problem – e.g. – might it be due to something like the pill.

This made me dig into the problem, and I may have found a way to treat those cases which are causing problems for the vaccine.

Short answer – the clotting incidents ARE related to the vaccine, but they should be very TREATABLE! And weirdly, just like PRESIDENT TRUMP was treated!

#################

OMG – you kicked me into a solution for the AstraZeneca problems!

I repeat – there is a way to treat the problem!

Here is my reasoning to the solution…..

Remember how I’ve been likening the spike protein to snake venom? Snake venoms are also proteins, with the main category (hemotoxic) having hematological and cardiovascular effects.

Spike protein-based vaccinations ARE thus totally analogous to snake expert Bill Haast’s self-experiments on building up resistance to snake venom by basically vaccinating himself with it. Totally analogous. He concentrated on NEUROTOXIC venoms (cobras, kraits, mambas), but those are also proteins, and it works the same way.

NOW – back to the AZ vaccine – they actually know what is going on with the AstraZeneca vaccines:

#################

https://www.sciencemag.org/news/2021/03/rare-clotting-disorder-may-cloud-worlds-hopes-astrazenecas-covid-19-vaccine

A rare clotting disorder may cloud the world’s hopes for AstraZeneca’s COVID-19 vaccine

By Kai Kupferschmidt, Gretchen Vogel
Mar. 27, 2021 , 10:20 AM

Science’s COVID-19 reporting is supported by the Heising-Simons Foundation.
In the tumultuous rollout of AstraZeneca’s COVID-19 vaccine, all eyes this week were on the United States, where the company had a highly public communication breakdown over the vaccine’s efficacy with an expert panel overseeing a large study in the Americas. But on the other side of the Atlantic Ocean, the vaccine faces new concerns about safety as an explanation gains ground for the unusual strokes and clotting disorders recorded in at least 30 recipients.
Many European countries suspended use of AstraZeneca’s vaccine earlier this month following initial reports of the symptoms, which have led to at least 15 deaths. Most resumed vaccinations after the European Medicines Agency (EMA) recommended doing so on 18 March, saying the benefits of the vaccine outweigh any risks. EMA is continuing to investigate the matter and will convene a wide-ranging committee of experts on 29 March.
Now, a group of researchers led by German clotting specialist Andreas Greinacher of the University of Greifswald says the highly unusual combination of symptoms—widespread blood clots and a low platelet count, sometimes with bleeding—resembles a rare side effect of the blood thinner heparin called heparin-induced thrombocytopenia (HIT).
The scientists, who first described their findings during a 19 March press conference, recommend a way to test for and treat the disorder and say this can help ease worries about the vaccine. “We know what to do: how to diagnose it, and how to treat it,” says Greinacher, who calls the syndrome vaccine-induced prothrombotic immune thrombocytopenia (VIPIT). Greinacher has posted a manuscript on the preprint server Research Square.
Even if Greinacher’s mechanism isn’t the whole story, multiple researchers told Science they were convinced the vaccine was causing the rare set of symptoms. If that turns out to be true, it could have major consequences for the vaccine, which is one of the cornerstones of the World Health Organization’s push to immunize the world. AstraZeneca is working with partners around the globe to make and distribute billions of doses in low- and middle-income countries, which might have a harder time identifying and treating rare side effects.

#################

NOW – here is the important part – what they think it is:

vaccine-induced prothrombotic immune thrombocytopenia (VIPIT)

they are naming it in analogy to something similar from heparin:

heparin-induced thrombocytopenia (HIT)

The key symptom is thrombocytopenia.

Well, I KNEW this was a common symptom of hemotoxic snake venoms, because the word was stuck in my mind from all the reading I did on those things.

So – searching on thrombocytopenia and snake venoms led me to this:

#################

https://pubmed.ncbi.nlm.nih.gov/12676300/

Case Reports 

J Emerg Med. 2003 Apr;24(3):289-93. 
doi: 10.1016/s0736-4679(02)00763-1.

Biphasic rattlesnake venom-induced thrombocytopenia

Steven R Offerman 1, J David Barry, Aaron Schneir, Richard F Clark

PMID: 12676300 DOI: 10.1016/s0736-4679(02)00763-1

Abstract

Thrombocytopenia is a common occurrence in moderate to severe crotaline envenomation. The exact mechanism by which rattlesnake venom leads to thrombocytopenia is unclear, but aggressive treatment with crotaline-specific antivenom often leads to resolution of this disorder. Crotalinae Polyvalent Immune Fab (CroFab(TM), Protherics Inc., Nashville, TN) (crotaline Fab) is now available for the treatment of symptomatic rattlesnake envenomation. Although recurrence of thrombocytopenia has been reported in patients after envenomation treated with crotaline Fab, cases refractory to this therapy have not been described. We report a case of severe crotaline envenomation that appears to have exhibited two separate episodes of thrombocytopenia, only one of which responded to antivenom. The second, later phase was refractory to both crotaline Fab as well as traditional Antivenin (Crotalinae) Polyvalent (Wyeth-Ayerst Pharmaceuticals, Philadelphia, PA) (ACP). By reviewing the literature regarding venom-induced thrombocytopenia, we attempt to explain this “biphasic” phenomenon and the inability of crotaline Fab to reverse this toxic effect.

#################

Here are the key points:

(1) Thrombocytopenia is a common occurrence in moderate to severe crotaline envenomation. 

These are pit vipers, which include rattlesnakes and most of the venomous snakes in America. They have hemotoxic venoms.

(2) The exact mechanism by which rattlesnake venom leads to thrombocytopenia is unclear, but aggressive treatment with crotaline-specific antivenom often leads to resolution of this disorder.

THIS IS THE KEY:

If aggressive treatment with antivenom works on these snake venoms, then it’s possible that similar treatment of the vaccine clotting patients with antibodies (natural or synthetic) to the exact same or similar stabilized spike proteins would work in the exact same way.

Now – here is some speculation.

IMO the main disadvantage of the mRNA-based vaccines, whether vectored by adenoviruses OR by lipid nanodroplets, is the same as the uncertainty of VIRAL outcomes themselves – there is no real metering of how much spike protein gets made. The “finished spike protein” vaccines like Novavax cannot introduce any more or less spike protein than they originally present. In comparison to Novavax, however, there is more “play” in how much spike protein results from an mRNA jab.

This is not a “forbidding” problem – most early vaccines using live, dead, or weakened viruses, were, to some extent, RNA or DNA vaccines – particularly live or weakened which caused actual infection to occur and then be stamped out. They did not control how much or how many proteins were created, but this would almost always be directly related to the amount of vaccine.

At this point, people should be able to see the problem. There are likely some very small number of people, when MILLIONS get vaccinated, who somehow turn on a small, broken-handled faucet of spike protein – some cells that just keep cranking it out, which “get ahead” of the immunity response to too great an extent, and lead to outlier symptoms.

Basically, spike protein envenomation.

This is fixable!

Treat like snakebite using products like Regeneron and Lilly.

#################

I really feel like the snake venom analogy is a real workhorse here – it has helped me see a lot of other things with COVID-19.